Global Programmable Infusion Pumps Market Evolving Opportunities with ICU Medical Inc. and B. Braun
The global programmable infusion pumps market and the market is poised to grow by USD 487.81 million during 2020-2024 at a CAGR of almost 8% during the forecast period.
The growing demand for self-administered drug delivery in home-care settings and technological advances is anticipated to boost the growth of the market.
Patients suffering from medical conditions such as cancer, diabetes, and arthritis are required to take medications on time without fail. This has increased the demand for self-administered therapeutic medications as per the recommendation of healthcare professionals because it improves the patients’ health outcome and minimizes the number of patients admitted to the hospital. Computerized ambulatory programmable drug infusion pumps are gaining prominence in home-care settings for administration of antibiotics and various other drugs. For instance, Becton, Dickson has developed a next-generation programmable infusion pump, the BodyGuard 545 Color Vision pump, which is designed for the administration of epidural analgesics. Thus, the growing demand for self-administered drug delivery in home-care settings is expected to drive market growth during the forecast period.
Major Five Programmable Infusion Pumps Market Companies:
B. Braun Melsungen AG
B. Braun Melsungen AG is headquartered in Germany and operates the business under various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum. The company offers a volumetric infusion pump, the Infusomat space pump.
Baxter International Inc.
Baxter International Inc. is headquartered in the US and offers products through the following business units: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies, and Other. The company offers an infusion pump, Spectrum IQ Infusion System, which is integrated with advanced electronic medical records (EMR).
Becton, Dickinson and Co.
Becton, Dickinson and Co. is headquartered in the US and operates under various business segments, namely Medical, Life sciences, and Interventional. The company offers BD Alaris pump module and BodyGuard ColourVision 323 ambulatory infusion pump.
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA is headquartered in Germany and offers products through the following business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The company offers an advanced standalone infusion pump, the Volumat MC Agilia.
ICU Medical Inc.
ICU Medical Inc. is headquartered in the US and offers products through the following business segments: Infusion Consumables, IV Solutions, Infusion Systems, and Critical Care. The company offers a smart infusion pump, the Plum 360 infusion system.
Market Competitive AnalysisThe programmable infusion pumps market is currently fragmented. The degree of fragmentation will decrease over the forecast period. Vendors are adopting inorganic growth strategies and making acquisitions primarily to improve their technological landscape and broaden their product offerings. Smiths Group Plc, Terumo Corp., and Ypsomed Holding AG. are a few of the significant market participants. Although the accelerating market growth momentum will offer immense business opportunities to the vendors, the availability of alternative drug delivery methods will challenge the growth of many. To make the most of the increasing programmable infusion pumps market size, market vendors should focus more on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market positions, this programmable infusion pumps market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of the companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. This programmable infusion pumps market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading programmable infusion pump companies, including:
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson, and Co.
- Fresenius SE & Co. KGaA
- ICU Medical Inc.
- Johnson & Johnson
- Medtronic Plc
- Smiths Group Plc
- Terumo Corp.
- Ypsomed Holding AG